C5 anticorps (N-Term)
Aperçu rapide pour C5 anticorps (N-Term) (ABIN2215985)
Antigène
Voir toutes C5 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 253-281, N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- C5, NT (Complement C5, C3 and PZP-like alpha-2-macroglobulin Domain-containing Protein 4, Complement C5 beta Chain, Complement C5 alpha Chain, C5a Anaphylatoxin, Complement C5 alpha' Chain, CPAMD4)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 253-281 in the N-terminal region of human C5, UniProt Accession #P01031.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- C5 (Complement Component 5 (C5))
-
NCBI Accession
- NP_001726
-
UniProt
- P01031
-
Pathways
- Système du Complément, Carbohydrate Homeostasis
Antigène
-